Professor Hongkui Deng named on Time Magazine TIME100 Health 2025 list of influential figures in global health RGB-5088 receives IND approval, marking China's first IND-approved PSC-product for T1D Global renowned pancreatic islet transplant expert Professor James Shapiro visits Gold Award of China Innovation and Entrepreneurship Competition (Zhejiang Division) Industry policy American Diabetes Association releases: Latest Phase I/II clinical data for VX-880 diabetes treatment New strategies for islet transplantation Selected for the 2023 Zhejiang Province "Leading Goose" R&D Project Plan Where is the future for diabetes patients? "The Reprogenix Study Group" opening ceremony was held successfully Nature Medicine publishes groundbreaking research results from Reprogenix

A review of academic achievements over the years Nature reports: Chinese stem cells reverse diabetes, a "world first" The first successful transplantation of chemically reprogrammed pluripotent stem cell-derived islets for the functional cure of a type 1 diabetes patient Release the latest results: artificial islet transplantation Stem cell therapy for diabetes has made a new breakthrough Nature Medicine publishes groundbreaking research results